Brokerages Set Oscar Health, Inc. (NYSE:OSCR) PT at $16.58

Shares of Oscar Health, Inc. (NYSE:OSCR - Get Free Report) have received a consensus rating of "Reduce" from the seven brokerages that are covering the firm, Marketbeat reports. Three analysts have rated the stock with a sell recommendation, three have given a hold recommendation and one has issued a buy recommendation on the company. The average 1-year price objective among brokers that have covered the stock in the last year is $16.58.

Several research firms have commented on OSCR. Raymond James Financial cut Oscar Health from an "outperform" rating to a "market perform" rating in a research note on Tuesday, June 24th. Wells Fargo & Company lowered Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their price target for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Wall Street Zen lowered Oscar Health from a "buy" rating to a "hold" rating in a research report on Sunday, June 8th. Piper Sandler lowered their price target on Oscar Health from $25.00 to $18.00 and set an "overweight" rating on the stock in a research report on Monday, June 9th. Finally, Barclays initiated coverage on Oscar Health in a research report on Wednesday, July 2nd. They set an "underweight" rating and a $17.00 price target on the stock.

Oscar Health Stock Down 3.2%

NYSE OSCR traded down $0.53 during trading on Friday, hitting $16.02. The stock had a trading volume of 29,908,768 shares, compared to its average volume of 6,635,535. The company has a market capitalization of $4.08 billion, a PE ratio of 57.21 and a beta of 1.90. The company's 50-day moving average price is $16.23 and its two-hundred day moving average price is $14.85. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.88 and a current ratio of 0.88. Oscar Health has a 12 month low of $11.20 and a 12 month high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.83 by $0.09. The firm had revenue of $3 billion for the quarter, compared to analysts' expectations of $2.87 billion. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The business's quarterly revenue was up 42.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.62 EPS. As a group, sell-side analysts forecast that Oscar Health will post 0.69 EPS for the current year.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the transaction, the director owned 64,512 shares of the company's stock, valued at $1,059,932.16. The trade was a 27.93% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 24.39% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in OSCR. JPMorgan Chase & Co. increased its holdings in shares of Oscar Health by 348.7% during the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock worth $139,246,000 after acquiring an additional 8,051,379 shares during the last quarter. BIT Capital GmbH increased its holdings in shares of Oscar Health by 5,711.6% during the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock worth $60,129,000 after acquiring an additional 4,396,872 shares during the last quarter. Deerfield Management Company L.P. Series C increased its holdings in shares of Oscar Health by 50.7% during the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock worth $159,062,000 after acquiring an additional 3,983,325 shares during the last quarter. Nuveen LLC acquired a new position in shares of Oscar Health during the 1st quarter worth approximately $29,684,000. Finally, Gilder Gagnon Howe & Co. LLC increased its holdings in shares of Oscar Health by 51.4% during the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock worth $85,154,000 after acquiring an additional 2,151,256 shares during the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.